# Geneseeq Technology

participates in China's precision-oncology genomic testing market as part of the country's growing domestic multi-omic testing base.

Source: https://en.bioecon.ru/companies/geneseeq-technology/
Updated: 2026-07-20

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Capacity | High-throughput sequencing capacity with 310,000+ clinical samples processed to date | https://na.geneseeq.com/our-technology-2/ |
| Certification | CAP, CLIA, ISO 15189, and ISO 13485 certifications for laboratories and manufacturing facilities | https://biobase.whitefordresearch.com/companies/geneseeq-technology, https://na.geneseeq.com/geneseeq-receives-nmpa-approval-for-pantrkare-chinas-first-ngs-based-pan-solid-tumor-companion-diagnostic-kit-for-ntrk-gene-fusions/, https://na.geneseeq.com/wp-content/uploads/2025/10/ISO-13485-Certificate-%EF%BC%88UL%EF%BC%89.pdf |
| Regulatory approval | Multiple NMPA approvals in China for diagnostic kits including PanTRKare and large-panel NGS assays, as well as U.S. FDA clearances and CE-IVD markings for various assays | https://na.geneseeq.com/geneseeq-receives-nmpa-approval-for-pantrkare-chinas-first-ngs-based-pan-solid-tumor-companion-diagnostic-kit-for-ntrk-gene-fusions/, https://www.prnewswire.com/news-releases/geneseeq-receives-nmpa-approval-for-pantrkare---chinas-first-ngs-based-pan-solid-tumor-companion-diagnostic-kit-for-ntrk-gene-fusions-302610192.html, https://www.vcbeathealth.com/article/59323 |
| Production site | Core laboratories in Nanjing, Shanghai, Beijing, and Guangzhou; manufacturing facility in Nanjing | https://biobase.whitefordresearch.com/companies/geneseeq-technology, https://www.prnewswire.com/news-releases/geneseeq-and-astrazeneca-collaborate-to-build-guangzhou-bio-diagnostics-innovation-center-301276980.html |
| Headcount | 339 employees reported in 2025 annual report; other reports estimate over 1,500 professionals (2025-12-31) [medium confidence] | https://qiye.qizhidao.com/company/b41e1887d23421f09f7b2f89eceeb303.html, https://www.investnj.org.cn/our-clients/client-profiles/geneseeq-technology-nanjing%ef%bf%bc/ |
| Revenue | RMB 577 million for full-year 2025 (2025-12-31) | https://qiye.qizhidao.com/company/b41e1887d23421f09f7b2f89eceeb303.html, https://www.vcbeathealth.com/article/59323 |

Independent sources: biobase.whitefordresearch.com, investnj.org.cn, na.geneseeq.com, prnewswire.com, qiye.qizhidao.com, vcbeathealth.com

## Technologies

- [Multi-omics diagnostic panels for precision oncology](https://en.bioecon.ru/technology/multi-omics-diagnostic-panels-precision-oncology/)